Yuanquan Yang

11PUBLICATIONS
49CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markersMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 28, 2026
Temporal dynamics of the immune response to neoadjuvant androgen deprivation therapy suggest a window of opportunity for checkpoint inhibitor therapy in prostate cancer.

|Jul 29, 2026
Multi-omic characterization of 14q deletion in renal clear cell carcinoma identifies EDNRB as a predictor of immunotherapy response.

|Jul 27, 2026
Phase II Randomized Trial of Radium-223 Dichloride and Cabozantinib in Patients With Renal Cell Carcinoma With Bone Metastases: RADICAL (Alliance A031801).

|Oct 17, 2025
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).

Mamta Parikh, Nataliya V Uboha, Naoko Takebe

|Jan 08, 2025
Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies.

Adam Khorasanchi, Karan Jatwani, Lingbin Meng

|Dec 19, 2024
Perioperative systemic therapy in high-risk renal cell carcinoma following nephrectomy: a narrative review.

Adam Khorasanchi, Taylor Goodstein, Shawn Dason

Pageof 2

Frequent Collaborators

2 joint publications

Adam Khorasanchi

2 joint publications

Mingjia Li

2 joint publications

Mamta Parikh

1 joint publications

Kent L Nastiuk